Microsize

Microsize, the largest independent CDMO based in the United States, specializes in micronization and particle size control. Microsize offers the "preferred" technology for enhancing the bioavailability of poorly soluble APIs (including HPAPIs) through micronization. The company possesses the experience and capability to rapidly develop, scale up, and process APIs and excipients (including highly potent compounds), ranging from grams to several metric tons, thereby enabling physicians to improve solubility and bioavailability through particle reduction technologies such as micronization.